Sarasin & Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$466M |
| 2 |
CME Group
CME
|
+$446M |
| 3 |
Merck
MRK
|
+$445M |
| 4 |
Amgen
AMGN
|
+$372M |
| 5 |
Colgate-Palmolive
CL
|
+$361M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$198M |
| 2 |
SIVB
SVB Financial Group
SIVB
|
+$59.9M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$51.1M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$36.4M |
| 5 |
FRC
First Republic Bank
FRC
|
+$26.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Financials | 16.64% |
| 3 | Industrials | 12.97% |
| 4 | Healthcare | 10.86% |
| 5 | Consumer Discretionary | 10.03% |
Similar funds
Sarasin & Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Sarasin & Partners held 103 positions worth $18.6B, up 143% from $7.64B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Sarasin & Partners deployed $8.32B of net new capital in Q1 2023, opening 13 new positions and adding to 78 existing holdings. Its largest new stake was Charter Communications: 202,753 shares worth $124M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $198M trimmed.
- Sarasin & Partners's largest Q1 2023 buy was Charter Communications: 202,753 shares worth $124M.
- Sarasin & Partners added most to Microsoft in Q1 2023, an estimated $466M increase.
- Sarasin & Partners's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $198M.
- Sarasin & Partners fully exited SVB Financial Group in Q1 2023, selling an estimated $59.9M.
- Sarasin & Partners's ten largest holdings make up 37% of its $18.6B portfolio in Q1 2023.
- Sarasin & Partners opened 13 new positions and closed 2 in Q1 2023.
- Sarasin & Partners's portfolio value rose 143% quarter-over-quarter to $18.6B.
Based on Sarasin & Partners's 13F filing for Q1 2023, filed 27 Apr 2023.